Condition

Impaired Fasting Glucose (IFG)

ClinicalTrials.gov condition label

Clinical trials5

Recruiting1

Common interventions7

Lead sponsors shown5

Clinical trials

5 shown

Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)NCT02969798 · 2014-01-01

Growth Hormone Resistance of Beta-cellsNCT07581860 · 2026-08-01

NOT_YET_RECRUITING

Effect of a Food Supplement on Glycemic Parameters in Patients With Impaired Glucose MetabolismNCT07263802 · 2025-12-01

NOT_YET_RECRUITING

Metformin and Its Impact on the Substances Associated With NO Production in Prediabetes Patients.NCT03398356 · 2017-10-20

A Survey on the Rate of Glucose Intolerance in Hong Kong ChineseNCT00787215 · 2008-11-01

Common interventions

MetforminDRUG2 DapagliflozinDRUG1 GlycoDualDIETARY_SUPPLEMENT1 observational: no treatment involvedOTHER1 PioglitazoneDRUG1 PlaceboOTHER1 SaxagliptinDRUG1

Leading sponsors

Chinese University of Hong Kong1 Fondazione IRCCS Policlinico San Matteo di Pavia1 The University of Texas Health Science Center at San Antonio1 University of Missouri-Columbia1 Wroclaw Medical University1

Trial status mix

NOT_YET_RECRUITING2

COMPLETED1

RECRUITING1

UNKNOWN1

Phase mix

NA2

PHASE41

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.